Lorviqua 100 mg FilmCoated Tablets

Lorviqua 100 mg FilmCoated Tablets

分类: Drug Info 当前有货
欲了解更多详情,请游览我们的官方网站 farmakopedia.com

详情

Manufacturer
Pfizer Manufacturing Deutschland GmbH.(GERMANY)

Registraction Number
MAL20126004AZ

Content:
Lorviqua 100 mg Film-Coated Tablets contain 100 mg of lorlatinib and 1.58 mg of lactose monohydrate as an excipient. The tablets are round, light pink, and debossed with "Pfizer" on one side and "100" and "LLN" on the other side.
Indications:
Lorviqua is indicated for the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC). It can be used as a monotherapy in patients who have not been previously treated with an ALK inhibitor, or in patients whose disease has progressed after treatment with other ALK inhibitors such as alectinib, ceritinib, or crizotinib.
Instructions:

更多 Complete Wellness 相关资料
Complete Wellness
Complete Wellness General Health | Healthy Lifestyle | Drug & Supplement Information Provider ~Complete Wellness